Diagnosis and monitoring of chromosome aberrations in hematological malignancies by fluorescence in situ hybridization

被引:11
作者
Dohner, H [1 ]
Stilgenbauer, S [1 ]
Fischer, K [1 ]
Schroder, M [1 ]
Bentz, M [1 ]
Lichter, P [1 ]
机构
[1] DEUTSCH KREBSFORSCHUNGSZENTRUM,W-6900 HEIDELBERG,GERMANY
关键词
fluorescence in situ hybridization (FISH); chronic lymphocytic leukemia; chronic myeloid leukemia; acute myeloid leukemia; residual disease;
D O I
10.1002/stem.5530130712
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Besides its application in biological research, fluorescence in situ hybridization (FISH) is increasingly used for the cytogenetic analysis of human malignancies. Compared to conventional cytogenetic analysis, FISH allows delineation of specific numerical and structural chromosome aberrations in interphase cells (interphase cytogenetics), We have developed sets of genomic DNA probes for the identification of chromosome aberrations associated with chronic lymphocytic leukemia (CLL), chronic myeloid leukemias (CML), and acute myeloid leukemia (AML). In CLL, interphase cytogenetics will greatly contribute to the evaluation of the true incidence of specific chromosome aberrations and will provide the basis for more accurate correlations with the clinical outcome, The Philadelphia chromosome can be detected by FISH with high specificity and sensitivity in both CML and acute lymphoblastic leukemia, In CML, it can be used to better assess the cytogenetic remission status following therapy with interferon-alpha, Finally, in AML interphase cytogenetics provides a rapid and reliable technique for the identification of chromosome aberrations which are one of the most important prognostic factors in this disease. With the design of complex DNA probe sets and the development of digital microscopy and automated image analysis, it will be possible to use such disease-specific probe sets for monitoring residual disease following chemotherapy.
引用
收藏
页码:76 / 82
页数:7
相关论文
共 28 条
[1]   DETECTION OF THE PHILADELPHIA-CHROMOSOME IN INTERPHASE NUCLEI [J].
ARNOLDUS, EPJ ;
WIEGANT, J ;
NOORDERMEER, IA ;
WESSELS, JW ;
BEVERSTOCK, GC ;
GROSVELD, GC ;
VANDERPLOEG, M ;
RAAP, AK .
CYTOGENETICS AND CELL GENETICS, 1990, 54 (3-4) :108-&
[2]  
AUTIO K, 1986, EUR J HAEMATOL, V39, P289
[3]   DETECTION OF CHIMERIC BCR-ABL GENES ON BONE-MARROW SAMPLES AND BLOOD SMEARS IN CHRONIC MYELOID AND ACUTE LYMPHOBLASTIC-LEUKEMIA BY IN-SITU HYBRIDIZATION [J].
BENTZ, M ;
CABOT, G ;
MOOS, M ;
SPEICHER, MR ;
GANSER, A ;
LICHTER, P ;
DOHNER, H .
BLOOD, 1994, 83 (07) :1922-1928
[4]  
BENTZ M, 1994, LEUKEMIA, V8, P1447
[5]  
BLOOMFIELD CD, 1987, SEMIN ONCOL, V14, P372
[6]   EVIDENCE FOR A NEW TUMOR SUPPRESSOR LOCUS (DBM) IN HUMAN B-CELL NEOPLASIA TELOMERIC TO THE RETINOBLASTOMA GENE [J].
BROWN, AG ;
ROSS, FM ;
DUNNE, EM ;
STEEL, CM ;
WEIRTHOMPSON, EM .
NATURE GENETICS, 1993, 3 (01) :67-72
[7]   CLONING OF LARGE SEGMENTS OF EXOGENOUS DNA INTO YEAST BY MEANS OF ARTIFICIAL CHROMOSOME VECTORS [J].
BURKE, DT ;
CARLE, GF ;
OLSON, MV .
SCIENCE, 1987, 236 (4803) :806-812
[8]  
COHEN D, 1993, NATURE, V366, P398
[9]   DETECTION OF CHROMOSOME-ABERRATIONS IN THE HUMAN INTERPHASE NUCLEUS BY VISUALIZATION OF SPECIFIC TARGET DNAS WITH RADIOACTIVE AND NONRADIOACTIVE INSITU HYBRIDIZATION TECHNIQUES - DIAGNOSIS OF TRISOMY-18 WITH PROBE L1.84 [J].
CREMER, T ;
LANDEGENT, J ;
BRUCKNER, A ;
SCHOLL, HP ;
SCHARDIN, M ;
HAGER, HD ;
DEVILEE, P ;
PEARSON, P ;
VANDERPLOEG, M .
HUMAN GENETICS, 1986, 74 (04) :346-352
[10]   P53 GENE DELETION PREDICTS FOR POOR SURVIVAL AND NONRESPONSE TO THERAPY WITH PURINE ANALOGS IN CHRONIC B-CELL LEUKEMIAS [J].
DOHNER, H ;
FISCHER, K ;
BENTZ, M ;
HANSEN, K ;
BENNER, A ;
CABOT, G ;
DIEHL, D ;
SCHLENK, R ;
COY, J ;
STILGENBAUER, S ;
VOLKMANN, M ;
GALLE, PR ;
POUSTKA, A ;
HUNSTEIN, W ;
LICHTER, P .
BLOOD, 1995, 85 (06) :1580-1589